EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 79 filers reported holding EIDOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $27,153,000 | +175.3% | 206,358 | -0.1% | 0.10% | +114.9% |
| Q3 2020 | $9,864,000 | +0.1% | 206,539 | -0.1% | 0.05% | -2.1% |
| Q2 2020 | $9,853,000 | -2.7% | 206,688 | +0.0% | 0.05% | -12.7% |
| Q1 2020 | $10,125,000 | -14.8% | 206,671 | -0.2% | 0.06% | +19.6% |
| Q4 2019 | $11,883,000 | +59.6% | 207,056 | +0.0% | 0.05% | +53.3% |
| Q3 2019 | $7,445,000 | +15.7% | 206,988 | -0.0% | 0.03% | +20.0% |
| Q2 2019 | $6,435,000 | +11.8% | 207,037 | -15.6% | 0.02% | +13.6% |
| Q1 2019 | $5,754,000 | +74.4% | 245,362 | +2.3% | 0.02% | +57.1% |
| Q4 2018 | $3,300,000 | +37.9% | 239,776 | -0.0% | 0.01% | +75.0% |
| Q3 2018 | $2,393,000 | – | 239,812 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,162,671 | $43,989,000 | 2.86% |
| Foresite Capital Management IV, LLC | 245,082 | $4,985,000 | 1.70% |
| Cormorant Asset Management, LP | 385,846 | $7,455,000 | 0.55% |
| Monashee Investment Management LLC | 125,000 | $2,543,000 | 0.48% |
| Perceptive Advisors | 686,922 | $13,971,000 | 0.37% |
| Board of Trustees of The Leland Stanford Junior University | 179,072 | $3,642,000 | 0.35% |
| DC Investments Management, LLC | 25,952 | $528,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 323,807 | $6,586,000 | 0.23% |
| VIKING GLOBAL INVESTORS LP | 1,986,201 | $40,399,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 49,833 | $1,014,000 | 0.16% |